Customs Organization to sign declaration against counterfeit drugs

The World Customs Organization (WCO) will sign a declaration to fight the $200-billion-a-year counterfeit drug industry, Reuters reports.

"Fake medicines often contain the wrong or toxic ingredients and pose a growing health threat worldwide, especially in poor countries where drugs are sold to treat conditions such as malaria, tuberculosis and HIV," the article states.  According to the World Trade Organization, "fake anti-malaria drugs kill 100,000 Africans a year and the black market deprives governments of 2.5 - 5 percent of their revenue," Reuters reports.

The declaration will be signed June 24 and will "ban the making and marketing of counterfeit drugs." WCO's Christophe Zimmerman said he hopes the declaration will "lend legitimacy to proposals to revamp obsolete legislation and improve coordination between enforcement agencies" (Irish, 6/10).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Small Solutions for Big Problems in Drug Discovery and Delivery